Synergistic Anticancer Efficacy of Curcumin and Doxorubicin Combination Treatment Inducing S-phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells: An In Vitro Study

Cur synergistically chemo-sensitizes the anticancer activity of Doxo and enhances the responses toward conventional chemotherapy attenuating breast cancer.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-12-03
DOI
https://doi.org/10.7759/cureus.75047
Citations
5
Primary Topic
Curcumin's Biomedical Applications
Type
article
Field-Weighted Citation Impact
0.85
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synergistic Anticancer Efficacy of Curcumin and Doxorubicin Combination Treatment Inducing S-phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells: An In Vitro Study

Rumana Ahmad, Esha Sarkar, Afreen Khan, Abbas Ali Mahdi et al.
5 citations
Cureus
Curcumin's Biomedical Applications
0.85
article

Synergistic Anticancer Efficacy of Curcumin and Doxorubicin Combination Treatment Inducing S-phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells: An In Vitro Study

Rumana Ahmad, Esha Sarkar, Afreen Khan, Abbas Ali Mahdi, Syed Tasleem Raza, Aparna Misra
article en
5 citations

Abstract

Cur synergistically chemo-sensitizes the anticancer activity of Doxo and enhances the responses toward conventional chemotherapy attenuating breast cancer.

CureusVol. 16(12)
Era's Lucknow Medical College and Hospital (IN)
Good health and well-being
Openalex Percentile: Top 30%
Curcumin's Biomedical Applications
0.85
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.